TW200518774A - Volatile proof solid preparation and producing method thereof - Google Patents
Volatile proof solid preparation and producing method thereofInfo
- Publication number
- TW200518774A TW200518774A TW093134088A TW93134088A TW200518774A TW 200518774 A TW200518774 A TW 200518774A TW 093134088 A TW093134088 A TW 093134088A TW 93134088 A TW93134088 A TW 93134088A TW 200518774 A TW200518774 A TW 200518774A
- Authority
- TW
- Taiwan
- Prior art keywords
- evaporating
- volatile
- solid preparation
- producing method
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This invention provides a technique for more simply reducing formation of whiskers or generation of an unpleasant odor of a solid pharmaceutical preparation. It comprises an agent that is evaporating by an evaporating degraded substance thereof than a conventional technique. The characteristic provides evaporation preventing type solid pharmaceutical preparation. The manufacturing method is that it comprises the agent that is evaporating at least by the evaporating degraded substance thereof, and carboxymethyl-cellulose or its salt as an evaporation-preventing agent.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003399851A JP5248733B2 (en) | 2003-11-28 | 2003-11-28 | Volatilization-preventing solid preparation and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200518774A true TW200518774A (en) | 2005-06-16 |
TWI333421B TWI333421B (en) | 2010-11-21 |
Family
ID=34724286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093134088A TW200518774A (en) | 2003-11-28 | 2004-11-09 | Volatile proof solid preparation and producing method thereof |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5248733B2 (en) |
KR (1) | KR20050052361A (en) |
CN (1) | CN1636553A (en) |
TW (1) | TW200518774A (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI367755B (en) * | 2005-05-20 | 2012-07-11 | Sankyo Co | Film coated product |
JP2007131561A (en) * | 2005-11-09 | 2007-05-31 | Ss Pharmaceut Co Ltd | Oral solid preparation and method for producing the same |
JP2008127350A (en) * | 2006-11-22 | 2008-06-05 | Ss Pharmaceut Co Ltd | Deodorizing solid composition |
JP5201819B2 (en) * | 2006-11-22 | 2013-06-05 | エスエス製薬株式会社 | Solid composition |
TWI392505B (en) * | 2006-11-22 | 2013-04-11 | Ssp Co Ltd | Solid composition |
TWI442947B (en) * | 2006-12-07 | 2014-07-01 | Daiichi Sankyo Co Ltd | Film coating formulations of improved stability |
BRPI0719393B8 (en) | 2006-12-07 | 2021-05-25 | Daiichi Sankyo Co Ltd | pharmaceutical composition |
JP5733930B2 (en) * | 2009-09-09 | 2015-06-10 | 武田薬品工業株式会社 | Solid preparation |
KR102209574B1 (en) * | 2019-10-08 | 2021-02-01 | 주식회사 에스엔비아 | Composition for deodorization of thiols |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61129138A (en) * | 1984-11-16 | 1986-06-17 | Takeda Chem Ind Ltd | Coated medicinal drug |
GB8629567D0 (en) * | 1986-12-10 | 1987-01-21 | Boots Co Plc | Therapeutic agents |
US4837031A (en) * | 1987-09-17 | 1989-06-06 | Mallinckrodt, Inc. | Compositions containing ibuprofen |
JP2591235B2 (en) * | 1989-03-30 | 1997-03-19 | 吉富製薬株式会社 | Stable tablet containing alkyl cysteine or acid addition salt thereof |
JP3172749B2 (en) * | 1992-02-17 | 2001-06-04 | ライオン株式会社 | Ibuprofen-containing preparation |
JPH0656677A (en) * | 1992-08-03 | 1994-03-01 | Lion Corp | Antacid composition |
JPH08310953A (en) * | 1995-05-22 | 1996-11-26 | Lion Corp | Solid composition |
US6248391B1 (en) * | 1997-07-16 | 2001-06-19 | Bpsi Holdings, Inc. | Bright white film coatings and film coating compositions therefor |
HUP0104606A3 (en) * | 1998-12-18 | 2003-01-28 | Basf Ag | A pharmaceutical mixture comprising a profen |
DE10003757A1 (en) * | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen drug preparation |
-
2003
- 2003-11-28 JP JP2003399851A patent/JP5248733B2/en not_active Expired - Lifetime
-
2004
- 2004-11-09 TW TW093134088A patent/TW200518774A/en not_active IP Right Cessation
- 2004-11-25 KR KR1020040097230A patent/KR20050052361A/en not_active Application Discontinuation
- 2004-11-26 CN CNA2004100961166A patent/CN1636553A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1636553A (en) | 2005-07-13 |
JP2005162619A (en) | 2005-06-23 |
KR20050052361A (en) | 2005-06-02 |
JP5248733B2 (en) | 2013-07-31 |
TWI333421B (en) | 2010-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200518774A (en) | Volatile proof solid preparation and producing method thereof | |
GEP20094847B (en) | Novel phenyl-propargylether derivatives | |
ATE523504T1 (en) | 1-THIO-D-GLUCITOL DERIVATIVES | |
MX2007013623A (en) | External preparation for skin. | |
DE10190041D2 (en) | Implants, particles | |
ATE477311T1 (en) | COATING COMPOSITION AND METHOD | |
EA200600320A1 (en) | γ-CRYSTALLINE FORM OF Ivabradine Hydrochloride, its Method of Production and Pharmaceutical Compositions That It Contains | |
EA200600321A1 (en) | βd-CRYSTALLINE FORM OF Ivabradine Hydrochloride, its Method of Production and Pharmaceutical Compositions That It Contains | |
WO2003000200A3 (en) | β-2'-OR 3'-HALONUCLEOSIDES | |
BRPI0017067B8 (en) | cell division inhibitor, dehydrogenase, method for producing a compound and cell division inhibitor | |
PL1812542T3 (en) | Fragrance combination comprising 3,7-dimethyloct-6-ene nitrile (citronellyl nitrile) as geranonitrile substitute | |
WO2002016026A3 (en) | Adsorbent and/or catalyst compounds promoted with halide ions and methods of making and using thereof | |
FR2884426B1 (en) | INSTALLATION FOR THE STERILIZATION OF OBJECTS BY ELECTRON BOMBING. | |
CA2427988A1 (en) | Tobacco odor deodorizing perfume composition, tobacco odor deodorant, cigarette low in sidestream smoke odor, and tobacco package | |
RU2008112676A (en) | Antitumor agent | |
ATE359279T1 (en) | MUSK ODORS | |
BR0209327A (en) | Composition for treatment of drug-induced constipation | |
GB0326904D0 (en) | Formation of self-assembled monolayers | |
EA200701687A1 (en) | Amorphous hydrochloride lorkanidipine | |
ATE395908T1 (en) | MELT GRANULATION OF A COMPOSITION CONTAINING A CALCIUM-CONTAINING COMPOUND | |
DK1301077T3 (en) | Antimicrobial preparation useful for the treatment of bovine mastitis | |
BR0307303A (en) | Process for the manufacture of hmg-coa reductase inhibitors | |
AR050452A1 (en) | DERIVATIVES OF CCI-779 | |
WO2004047663A3 (en) | Oral compositions which mask the salty taste of salts | |
ATE296298T1 (en) | FRAGRANCE PRECURSOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |